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Atrial natriuretic peptide (ANP) and its guanylyl cyclase-A (GC-A) receptor are being involved in
metabolism, although their role in the endocrine pancreas is still greatly unknown. The aim of this
work is to study a possible role for the ANP/GC-A system in modulating pancreatic -cell function.
The results presented here show a direct effect of the GC-A receptor in regulating glucose-stim-
ulated insulin secretion (GSIS) and -cell mass. GC-A activation by its natural ligand, ANP, rapidly
blocked ATP-dependent potassium (KATP) channel activity, increased glucose-elicited Ca
2 signals,
and enhanced GSIS in islets of Langerhans. The effect in GSIS was inhibited in islets from GC-A
knockout (KO) mice. Pancreatic islets from GC-A KO mice responded to increasing glucose con-
centrations with enhanced insulin secretion compared with wild type (WT). Remarkably, islets from
GC-A KO mice were smaller, presented lower -cell mass and decreased insulin content. However,
glucose-induced Ca2 response was more vigorous in GC-A KO islets, and basal KATP channel activity
in GC-A KO -cells was greatly diminished compared with WT. When protein levels of the two KATP
channel constitutive subunits sulfonylurea receptor 1 and Inward rectifier potassium channel 6.2
were measured, both were diminished in GC-A KO islets. These alterations on -cell function were
not associated with disruption of glucose tolerance or insulin sensitivity in vivo. Glucose and insulin
tolerance tests were similar in WT and GC-A KO mice. Our data suggest that the ANP/GC-A system
may have a modulating effect on -cell function. (Endocrinology 151: 3665–3674, 2010)
Atrial natriuretic peptide (ANP) is a component of thenatriuretic peptide family, which also includes brain
natriuretic peptide (BNP), and C-type natriuretic peptide.
The main receptor for ANP is guanylyl cyclase-A (GC-A/
Npr-A). This receptor is a member of the family of GCs
comprising GC-A to GC-G (1, 2). ANP and GC-A are
involved in maintaining blood pressure and cardiac
growth. In fact, ANP knockout (KO) and GC-A KO mice
share hypertension and cardiac hypertrophy (2). Recent
studies suggest a role for natriuretic peptides and their
receptors in modulating metabolism through increasing
lipolysis (3–6). Elevated plasma levels of ANP are found
during acute hyperglycemia in type 1 diabetes mellitus (7),
and ventricular ANP gene expression is increased in strep-
tozotocin-induced diabetic rats (8).
The islet of Langerhans is the main tissue involved in
maintaining blood glucose homeostasis, and its dysfunc-
tion is an essential factor in the development of type 1 and
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type 2 diabetes mellitus (9, 10). Insulin secretion in pan-
creatic -cells is driven by the ATP-dependent potassium
(KATP) channels and calcium entry (11).
It has been shown that GC-A is present in pancreatic
-cells (12, 13). Interestingly, You and Laychock (13)
have demonstrated that ANP, likely through activation of
GC-A, regulates pancreatic -cell growth. A possible in-
sulinotropic action for ANP/GC-A is still a matter of con-
troversy. It was demonstrated that ANP elicits an increase
in circulating insulin in humans (14) and stimulates insulin
secretion in rats (15), whereas in other studies, ANP pro-
duced no significant insulinotropic action or even inhib-
ited glucose-stimulated insulin secretion (GSIS) (13, 16,
17). Cyclic GMP, the second messenger produced by the
activation of GC-A by ANP, blocks KATP channels and
enhances glucose-induced calcium signaling in mouse
-cells (18). Moreover, GC-A is involved in the insulino-
tropic effect of 17-estradiol in mouse -cells through
modulation of KATP channels (12).
The aim of this work is to study a possible role for the




Fura 2-acetoxymethyl ester was obtained from Molecular
Probes (Invitrogen, Barcelona, Spain) and human insulin from
Lilly (Humulina Regular, Madrid, Spain). All other chemicals
were obtained from Sigma (Madrid, Spain).
Animals
Female mice with global deletion of GC-A (GC-A KO) and
corresponding wild-type (WT) mice were generated by the group
of D. L. Garbers (University of Texas Southwestern Medical
Center, Dallas, TX) (19). Other mice used in this work are C57
female and OF-1 male and female. Mice were 3–4 months old,
unless otherwise stated. All animals were kept under standard
housing conditions. A committee on internal animal care and use
reviewed and approved the method used.
Islet and islet cells isolation
Pancreatic islets of Langerhans were isolated by collagenase
(Sigma) digestion as previously described (20). Islets were dis-
persed into single cells with trypsin. Cells were then centrifuged
and resuspended in RPMI 1640 without phenol-red (Invitrogen)
and with 10% charcoal dextran-treated fetal bovine serum (Hy-
Clone, Logan, UT), 2 mM L-glutamine, 200 U/ml penicillin, and
0.2 mg/ml streptomycin. Cells were then plated in covers and
used within 24 h of culture.
Patch-clamp recordings
KATP channel activity was recorded using standard patch-
clamp recording procedures from isolated islet cells. Currents
were recorded using an Axopatch 200B patch-clamp amplifier
(Axon Instruments Co., Union City, CA). Patch pipettes were
pulled from borosilicate capillaries (Sutter Instruments Co., No-
vato, CA) using a flaming/brown micropipette puller P-97 (Sut-
ter Instruments Co.) with resistance between 3–5 M when filled
with the pipettes solutions as specified below. Bath solution con-
tained (in mM): 5 KCl, 135 NaCl, 2.5 CaCl2, 10 HEPES, and 1.1
MgCl2 (pH 7.4) and supplemented with glucose as indicated.
The pipette solution contained (in mM): 140 KCl, 1 MgCl2, 10
HEPES, and 1 EGTA (pH 7.2). The pipette potential was held at
0 mV throughout recording. KATP channel activity was quanti-
fied by digitizing 60-sec sections of the current record, filtered at
1 kHz, sampled at 10 kHz by a Digidata 1322A (Axon Instru-
ments Co.), and calculating the mean open probability (NPo) of
the channel during the sweep. Channel activity was defined as the
product of N, the number of functional channels, and Po, the
open-state probability. Po was determined by dividing the total
time channels spent in the open state by the total sample time.
Data sampling was started 1 min before (control) and 5 min after
application of test substances. Experiments were carried out at
room temperature (20–24 C).
Insulin secretion measurement
Pancreatic islets of Langerhans were cultured in the same
medium as islet cells described above. After 24 h in culture, islets
were incubated at 37 C in groups of five islets in a buffer solution
containing 120 mM NaCl, 25 mM NaHCO3, 5 mM KCl, 2.5 mM
CaCl2, 1 mM MgCl2, and 3 mM D-glucose (final pH 7.35). After
2 h, the solution was replaced by fresh solution containing the
different stimuli, and the islets were incubated for an additional
hour at 37 C. Afterwards, the medium was collected, and insulin
was measured in duplicate samples by RIA using a Coat-a-Count
kit (Siemens, Los Angeles, CA).
Insulin content measurement
Freshly isolated islets were hand picked in batches of 10 and
lysed overnight in an ethanol/HCl buffer at 4 C. Islets from the
insulin secretion experiments were subjected to the same proto-
col. After the overnight incubation, the buffer was removed, and
insulin was determined by RIA. Protein content was determined
using the Bradford dye method.
Recording [Ca2]i
Freshly isolated islets of Langerhans were loaded with 5 M
Fura 2-acetoxymethyl ester for at least 1 h at room temperature.
Calcium recordings in the whole islet of Langerhans were ob-
tained by imaging intracellular calcium under an inverted epi-
fluorescence microscope (Axiovert 200; Zeiss, Jena, Germany).
Images were acquired every 2 sec with an extended Hamamatsu
Digital Camera C4742-95 (Hamamatsu Photonics, Barcelona,
Spain) using a dual filter wheel (Sutter Instrument Co.) equipped
with 340 and 380 nm, 10-nm bandpass filters (Omega Optics,
Madrid, Spain). Data were acquired using Aquacosmos soft-
ware from Hamamatsu (Hamamatsu Photonics). Fluores-
cence changes are expressed as the ratio of fluorescence at 340
and 380 nm (F340/F380). Results were plotted and analyzed
using commercially available software (Sigmaplot; Jandel Sci-
entific, Corte Madera, CA).
Islet size
Transmission images from isolated whole islets were taken us-
ing a confocal Zeiss Pascal 5 microscope and a Zeiss 40 objective
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(numerical aperture, 1.3). Islets were focused in the plane with the
maximum area, and images were taken. Afterwards, the area of
those planes was quantified using LSM Zeiss software (Zeiss) as
m2 and used as the “islet size.” At least 400 islets from three
different mice were measured per condition.
-Cell mass
Mice were anesthetized with a combination of ketamine (70
mg/kg), diazepam (5.6 mg/kg), and atropine (0.5 mg/kg). A mid-
laparotomy was performed, the pancreas was exposed, the an-
imal was killed, and the pancreas was immediately dissected
from surrounding tissues, cleared of fat and lymph nodes, blot-
ted, weighed, and fixed in 4% paraformaldehyde fixative and
processed for paraffin embedding. The weight of the pancreas
was determined on a Mettler balance type A240 reading to
0.01 mg (Mettler Instruments Corp., Hightstown, NJ). -Cell
mass was measured by point-counting morphometry on immu-
noperoxidase-stained sections for insulin [rabbit antihuman insulin
antibody (1:50); Santa Cruz Biotechnology, Inc., Santa Cruz, CA],
using a 48-point grid to obtain the number of intercepts over -cells
(21, 22). -Cell mass was obtained by multiplying the weight of the
graft by the relative -cell volume.
In vivo experiments
All the in vivo experiments were performed in between 0800
and 1000 h. Blood glucose was obtained from the tail vein using
an Accu-check portable glucometer (Roche Diagnostic GmbH,
Mannheim, Germany). For determination of fasting blood glu-
cose levels and the ip glucose tolerance test (IPGTT), mice were
separated the previous evening and fasted for 12–14.5 h. For the
IPGTT, a dose of 2 g of glucose/kg body weight in a total volume
of 200 l saline solution was injected ip. For the insulin tolerance
test (ITT), fed mice were separated 2 h before the experiment,
and 1 IU/kg body weight of human insulin (Lilly; Humulina
Regular) was injected ip in 200 l total saline solution. For glu-
cose sensitivity, we measured the incremental area under the
curve (AUC) (23, 24).
To measure plasma insulin, mice were anesthetized with 70
mg/kg body weight sodium pentobarbital. Blood was obtained
by cardiac puncture with a syringe containing EDTA. Levels of
plasma insulin were determined by ELISA using the ultrasensi-
tive mouse insulin assay kit from Mercodia AB (Uppsala, Swe-
den). In some samples from the fasted state experiment, insulin
concentrations were below the detection level of the ELISA.
These samples were three per condition and were given the value
of the detection limit of the assay (0.025 g/liter).
Western blot analyses
Freshly isolated islets were obtained by centrifugation and
resuspended in cell lysis buffer (Cell Signaling Technology, Dan-
vers, MA). Cell extracts were subjected to SDS-PAGE (12%
gels). Prestained SDS-PAGE standards were included for molec-
ular mass estimation. The transfer to polyvinylidene mem-
branes was performed at 125 mA for 90 min in a buffer with
2.5 mM Tris base, 9 mM glycine, and 20% methanol. Mem-
branes were blocked with 2% nonfat dry milk and incubated
with the anti-sulfonylurea receptor 1 (Sur1) (1:100), anti-in-
ward rectifier potassium channel 6.2 (Kir6.2) (1:500), and
antiactin antibodies before being incubated with a peroxi-
dase-conjugated donkey antigoat (Santa Cruz Biotechnology,
Inc.) or goat antirabbit (GE Healthcare, Barcelona, Spain)
antibodies, respectively. Protein bands were revealed by using
the Enhanced Chemiluminiscence Reagents kit (Amersham
Biosciences, Barcelona, Spain).
Reduced nicotinamide adenine dinucleotide
(NADH) fluorescence
NADH autofluorescence was monitored using the same im-
aging system described for intracellular Ca2 recordings. NADH
fluorescence was excited with a 365-nm bandpass filter, whereas
emission was filtered at 445  25 nm (25). An image was ac-
quired every 60 sec.
See Supplemental Materials and Methods published on
The Endocrine Society’s Journals Online web site at
http://endo.endojournals.org.
Statistical analysis
Data are expressed as mean  SE. Pairwise comparisons were
made using Student’s t test, unless otherwise stated. A probabil-
ity level of 0.05 or lower was considered statistically significant.
Results
Activation of GC-A receptor by ANP increases
insulin secretion and insulin content in intact islets
of Langerhans
As described previously (12, 13), the ANP receptor,
GC-A, is expressed in pancreatic cells, both -cells and non-
-cells (Supplemental Fig. 1). 1 nM ANP increases insulin
secretion in pancreatic islets stimulated with glucose as
shown in Fig. 1A. This insulinotropic effect is not produced
at lower ANP concentrations. The involvement of GC-A in
this effect of ANP was studied on mice lacking GC-A. The
insulin secretion in response to 7 mM glucose was similar in
islets fromGC-AWTandKOmice.The insulinotropic effect
of ANP was fully inhibited in GC-A KO mice (Fig. 1B). In
addition, 1 nM ANP also increased insulin content in islets of
Langerhans within 1 h (Fig. 1C). This effect was only par-
tially inhibited by the absence of GC-A.
ANP regulates KATP channel activity and
glucose-induced [Ca2]i signals
We then studied the effect of ANP on KATP activity and
observed that 1 nM ANP produced a decrease in KATP
channel activity in WT -cells (Fig. 2, A and B). This de-
creased activity evoked an increase in [Ca2]i in the pres-
ence of stimulatory glucose concentration, as shown in
Fig. 2C. When the total entry of calcium into the cytosol
was measured as the AUC/min, it was higher in the pres-
ence of ANP (Supplemental Fig. 2A). The potentiation of
glucose-induced calcium signals is produced in islets ob-
tained from different mouse strains and independently of
sex (Supplemental Fig. 2B).
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Glucose regulation of insulin secretion in islets
from GC-A KO mice
We sought to functionally characterize pancreatic
-cells in islets from GC-A KO mice. GSIS was enhanced
in islets lacking GC-A. This effect was observed at both 11
and 16 mM glucose, whereas no genotype-dependent dif-
ference was observed under basal conditions or in re-
sponse to 7 mM glucose (Fig. 3).
Islet size and insulin content in islets from GC-A
KO mice
Islet size was measured as the islet area, and it was
found that islets from GC-A KO were 13% smaller than
those from WT mice (Fig. 4A). Moreover, when -cell
mass was measured, it tended to be lower at 2 months in
GC-A KO mice (P  0.09), and it was reduced at 8 months
compared with WT (P  0.059) (Fig. 4B). Notably, total
pancreas weight was similar in WT and KO mice at both
ages (Supplemental Fig. 3A). In addition, islets from GC-A
KO mice presented a striking decrease in insulin content
(Fig. 4C).
FIG. 1. ANP enhances insulin secretion and content in islets of
Langerhans. A, Insulin secretion measurements at different ANP
concentrations in 7 mM glucose (G); 11 mM glucose was used as
internal control (n  70 islets/condition from 14 mice). B, Insulin
secretion in response to 7 mM glucose plus 10 pM or 1 nM ANP in islets
from WT (n  70 islets/condition, six mice) and GC-A KO mice (n  40
islets/condition, four mice). C, Insulin content measured in the islets
after the secretion experiment in B. *, P  0.05 vs. 7 mM glucose;
, P  0.01 vs. 7 mM glucose; **, P  109 vs. 7 mM glucose.
FIG. 2. ANP decreases the KATP channel activity and increases [Ca
2]i.
A, A cell-attached patch-clamp recording of an isolated -cell is
shown. Several seconds of the same recording are shown at different
moments of the experiment. Diaz, Diazoxide; G, glucose. B, The NPo of
the KATP channel during control and ANP treatment was measured
(n  3 cells). *, P  0.05. C, [Ca2]i recording of an islet of
Langerhans in the presence of 8 mM glucose; 1 nM ANP was added to
the perfusion when indicated (n  6 islets).
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KATP channel activity and glucose-induced [Ca
2]i
signals in GC-A KO mice
The activity of the KATP was clearly diminished in -cells
from GC-A KO mice compared with WT in the absence of
glucose (control; Fig. 5, A–C). The use of 100 M diazoxide,
a KATP channel opener, rendered decreased activity in GC-A
KO -cells compared with WT (Fig. 5, A–C). The channels
in GC-A KO -cells were, nonetheless, functional and re-
sponded to 8 mM glucose similarly to those from WT mice
(Fig. 5, A, B, and D). The difference in the open probability
of KATP with diazoxide suggested a decreased number of
KATP channels in -cells. Indeed, Western blot analyses dem-
onstrated that both subunits of the channel, Sur1 and Kir6.2,
were decreased in islets from GC-A KO mice when normalized
to the levels of actin as the loading control (Fig. 6, A and B).
We then studied mitochondrial metabolism by measuring
NADH concentration. There was no change at 3 mM glucose,
a small increase in the response to8mM glucose, andnochange
was obtained at 16 mM glucose (Fig. 7, A and B). However, we
observed that Ca2 entry in response to 11 and 16 mM glucose
was increased in islets from GC-A KO mice (Fig. 7C). This was
measured as the percentage of time that the [Ca2]i remained
elevated above 50% of the maximum level (Fig. 7D). Basal lev-
els of intracellular calcium, at 3 mM glucose, did not differ be-
tween GC-A KO and WT mice (Supplemental Fig. 3B).
Glucose homeostasis in GC-A KO mice
We then analyzed blood glucose homeostasis in GC-A
KO mice. For this purpose, IPGTT and ITT were per-
formed. GC-A KO mice presented decreased body weight
both at 3 and at 8 months (Supplemental Fig. 3D). How-
ever, they did not present either glucose intolerance or
insulin resistance at any age tested (Fig. 8, A–C). In fact,
when incremental AUC was measured for the IPGTT, it
was significantly lower in GC-A KO mice at 8 months
(Supplemental Fig. 3C).
When glycemia was measured in both fasted and fed
states, the GC-A KO mice presented 20–30% increase in
the fasted state at all ages (Fig. 8D). However, glycemia in
the fed state was only statistically increased at 10 months
old (Fig. 8E). When insulin plasma levels were measured,
neither in the fasted nor in the fed states were they mod-
ified in GC-A WT vs. KO mice (Fig. 8F).
Discussion
In this work, we present evidence of an insulinotropic ef-
fect of ANP via activation of GC-A. This is reinforced by
FIG. 3. Islets from GC-A KO mice secrete more insulin in response to
glucose. Insulin secretion in response to increasing glucose
concentrations in islets from WT (n  70 islets/condition, six mice) and
GC-A KO mice (n  40 islets/condition, four mice). *, P  0.05 vs. WT;
#, P  0.05 vs. 3 mM glucose; , P  0.01 vs. 3 mM glucose.
FIG. 4. Islets from GC-A KO mice present smaller size, lower -cell
mass, and lower insulin content. A, The islet size from GC-A WT and
KO mice was calculated as the area at the widest diameter of the islet
(n  400 islets/condition, three mice). B, -Cell mass was measured in
islets from WT and KO mice of 2 and 8 months old (n  5–7 pancreas/
condition). C, Insulin content from freshly isolated islets from GC-A WT
and KO mice (n  80–100 islets/condition, four to five mice). *, P 
0.01; , P  0.05.
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the ANP-induced reduction of KATP channel activity and
the subsequent increase in [Ca2]i. In addition, insulin
content is also rapidly increased by ANP. The effect of
ANP on -cell function was abolished in islets from GC-A
KO mice, indicating that it was dependent on GC-A. Islets
from GC-A KO mice showed enhanced insulin secretion in
response to increasing glucose concentrations, whereas
basal insulin secretion did not change. This result was not
the consequence of increased islet size or -cell mass, be-
cause both were decreased in GC-A KO mice, as well as
islet insulin content. Remarkably, basal KATP channel ac-
tivity in GC-A KO -cells was diminished as a result of the
lowered Kir6.2 and Sur1 protein levels observed. In ad-
dition, the [Ca2]i response to increasing glucose concen-
trations was enhanced in GC-A KO mice. However, no
change in mitochondrial metabolism was observed in
GC-A KO mice that may explain the increase in GSIS.
These mice were smaller and had normal IPGTT and ITT.
GC-A KO mice presented, however, higher fasting glucose
levels, although under 100 mg/dl.
Natriuretic peptides ANP and BNP are being involved
in energy metabolism through the control of lipolysis in the
adipose tissue (3). Recently, the overexpression of BNP in
liver has been shown to protect against high-fat diet-induced
increase in body weight and total fat
weight. In addition, these mice presented
increased fat oxidation. Insulin resis-
tance, frequently associated with obesity,
was also improved (4). A model has been
proposed, in which ANP and BNP may
be important in preventing obesity and
type2diabetes (5). Incontrast, thestudies
of the effect of ANP on insulin secretion
have yielded discordant data. ANP has
been shown to increase plasma insulin in
humans (14) and GSIS in isolated rat is-
lets (15). However, in other studies with
rats, insulin secretion ex vivo did not
change in response to ANP (17) or was
even decreased after iv injection of the
peptide (16). Our data show that ANP
increases insulin secretion in mice islets in
a GC-A-dependent manner. In addition,
ANP blocks KATP channels and enhances
Ca2 signals in -cells. This modulation
of KATP and Ca
2 signals by ANP mimics
theeffectsof cyclicGMP, the secondmes-
senger produced by the activation of
GC-A by ANP, previously described in
-cells (18).
In the present work, we have used a
wide range of ANP concentrations (10
pM to 1 nM). The effect of ANP on insulin
secretion was only observed at 1 nM. In a series of studies in
humans, ANP plasma concentration ranged within
250–800 pM in normal and obese patients (26, 27). How-
ever,otherstudiesreportednormal levelsofANPintherange
of 1.1–13.7 pM for humans. Previous work reported basal
levels of ANP of 159  111 pM (n  4) in GC-A WT and
279  109 pM (n  5) in GC-A KO mice (28). The higher
circulatingANPconcentration inGC-AKOmice isprobably
related to arterial hypertension and cardiac pressure over-
load and hypertrophy. Most of the physiological effects of
ANP are through GC-A. However, we cannot rule out the
possible involvement of NPR-C, the clearance receptor, be-
cause it has been shown to modulate the cAMP/AC and PLC
signaling pathways (29, 30). Despite the discrepancy in nor-
mal plasma ANP levels, patients with heart or renal failure
presenthigherANPconcentration(forreview,pleaseseeRef.
2). Therefore, the insulinotropic effect of ANP at high con-
centrationmaybeimportant inregulating insulinsecretionin
heartandrenal failure. Inaddition, itwassuggestedyearsago
by Atlas and Maack (31) that ANP can be produced locally
at high concentrations acting as an emergency hormone to
counteract stress situations by favoring vasodilation, natri-
uresis,anddiuresisandmaybealso insulinrelease if thetarget
FIG. 5. KATP channel activity is diminished in GC-A KO mice. A, A cell-attached patch-clamp
recording of an isolated -cell from GC-A WT mice in the absence of glucose (G) [control
(Ctrl)] and at different moments of the experiment. B, The same as in A but from a GC-A KO
-cell. C, Graph plotting NPo in -cells from GC-A WT and KO mice in control and 100 M
diazoxide (Diaz) (n  6–7 cells per condition). *, P  0.01 vs. WT; **, P  0.05 vs. WT. D,
NPo in -cells from GC-A WT and KO mice in control and 8 mM glucose (n  4–5
cells/condition). *, P  0.0005; **, P  0.005 vs. control.
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is the -cell. In fact, recent studies suggested that ANP is
produced within the pancreas itself (32). Other studies indi-
cate that ANP is produced and released within the gastroin-
testinal mucosa, similarly as to incretin hormones (33).
Hence, much higher local concentrations of ANP might oc-
cur in or around the pancreas.
Surprisingly, islets fromGC-AKOmice responded toglu-
cose with higher insulin secretion than WT islets, despite the
smaller size and lower -cell mass of GC-A KO mice. The
decrease in -cell mass may have a body weight-dependent
component,because these twoparameters arepositively cor-
related (21). However, we cannot rule out an intrinsic defect
in the regulation of -cell mass in GC-A KO mice that
showed increased body weight between months 2 and 8
without a concomitant increment in -cell mass. In addition,
YouandLaychock(13)haverecentlyshownthatANP, likely
through GC-A activation, increases -cell growth and [3H]
thymidine incorporation in rat islet DNA, via Akt phosphor-
ylation.Therefore, it isplausible that in theabsenceofGC-A,
islets of Langerhans compensated the reduced -cell mass by
enhancing GSIS. This adaptation may be produced by a de-
crease in theexpressionof theKATP subunits Sur1andKir6.2
and therefore by reducing KATP channel activity at basal lev-
els, as described in the present work. KATP channels control
the resting membrane potential and determine the electrical
resistance of -cells. When KATP channels are open and the
membrane resistance is low, small currents will affect the
plasma membrane potential (and therefore, insulin release)
only minimally. However, when KATP channels are largely
closed and membrane resistance is high, small currents will
elicit the depolarization of the membrane, electrical activity,
Ca2 signals, and insulin release. Some of the features we
encountered in these GC-A KO mice resemble some models
described where the expression/function of KATP is lower or
null (34–36).The increasedGSIS (37,38)anddecreased islet
size and -cell mass (39) are shared with these models. How-
ever, some defects in blood glucose homeostasis and -cell
function described in these mice models, such as impaired
GTT (39–41), were not present in GC-A KO mice. There-
fore, the increase inGSISobservedinislets lackingGC-Amay
be the consequence of decreased KATP channel activity and
subunit levels. However, we cannot explain the in vivo phe-
notype of the GC-A KO mice solely by the decrease of KATP
channel activity. In addition, ANP is a pleiotropic hormone,
and apart from its hypotensive and hypovolemic actions and
role in blood pressure homeostasis, it has many different
neuroendocrineandmetaboliceffects. In thismodelofglobal
GC-A deletion, all cardiovascular and metabolic actions of
ANP are ablated, and therefore, fine physiological experi-
FIG. 6. KATP channel subunits expression is diminished in GC-A KO
mice. A, Sur1 and Kir6.2 subunits of the KATP channel were analyzed
by Western blotting. Actin is shown as loading control. B, Relative
amount of Sur1 and Kir6.2 in islets from GC-A WT and KO mice with
respect to actin (n  3 mice/condition). *, P  0.05 vs. WT.
FIG. 7. Glucose-induced -cell response is enhanced in GC-A KO mice.
A, Two [NADH]i recordings of a GC-A WT (upper panel) and KO (lower
panel) islet in response to glucose and cyanide (CN). Recordings start
with 3 mM glucose. B, Graph plotting the AUC/min in response to
different glucose concentrations (n  13–14 islets/condition, two mice). *,
P  0.05. C, Two [Ca2]i recordings of a GC-A WT (upper panel) and KO
(lower panel) islet in response to increasing glucose concentrations. D,
Graph plotting the percentage of the time that calcium is elevated above
half way at each glucose concentration from GC-A WT and KO mice (n 
16–17 islets/condition, three mice). *, P  0.05; , P  0.01.
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ments are difficult to exert. Even more, subtle changes (for
instance in glucose tolerance) might be masked by the com-
plex phenotype observed in these mice (hypervolemic hyper-
tension, cardiac hypertrophy).
Despite reduced islet size and -cell mass, GC-A KO
mice have normal glucose and insulin tolerance. It is plau-
sible that the adaptation process by enhancing GSIS pre-
vents the deterioration in glucose and insulin sensitivity. In
fact, both defects in -cell mass and -cell function are
required to develop diabetes, so that when one compen-
sates the other, glucose tolerance is
maintained unaltered (11). However,
islets from GC-A KO mice may fail to
properly respond to physiological situa-
tions in which insulin demand is in-
creased and blood glucose homeostasis
may be disrupted. In fact, GC-A /
mice fed with high-fat diet developed glu-
cose intolerance,whereas theoverexpres-
sion of BNP protected mice from devel-
oping high-fat diet-dependent insulin
resistance (4).
The persistently higher fasting glu-
cose levels in GC-A KO mice may be a
consequence of liver defects. Fasting
glycemia is mainly maintained by the
hepatic endogenous glucose production
(42), and in fact, hepatic insulin resis-
tance is thought to be largely responsi-
ble for the development of fasting hy-
perglycemia (43).
The importance of regulating the ex-
pression of KATP subunits is not con-
fined to -cells. The KATP channel is
also present in hypothalamic proopio-
melanocortin neurons, and it is in-
volved in insulin signaling, responsible
for decreasing hepatic glucose produc-
tion (44–47). In addition, KATP is also
present in cardiomyocytes, where it
plays a role in protecting the heart
against cardiac stress (48). In fact,
GC-A KO mice have a shorter life span
and some of them suffer sudden death
(49). The role that KATP may be playing
in this event is not known.
In summary, there is increasing evi-
dence supporting a role for natriuretic
peptides and their receptors in metabo-
lism and energy homeostasis (5). In this
work, we present evidence indicatingadi-
rect effect of the ANP/GC-A signaling in
-cell function and suggesting that the en-
docrine pancreas should be considered an important target for
natriuretic peptides and therefore contribute to their emerging
role in metabolism.
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